Table 1.
Summary of Bioactive Lipids and Their Roles in Glial Cell Modulation
| Lipid Class | Biosynthetic Enzymes | Primary Receptors | Role in Disease Stage |
|---|---|---|---|
| Eicosanoids | COX (Cyclooxygenase), LOX (Lipoxygenase) | EP1, EP2, EP3, EP4 (Prostaglandin receptors) | Involved in acute neuroinflammation, promoting inflammation initiation and persistence. |
| Specialized Pro-Resolving Mediators (SPMs) | LOX (Lipoxygenase) | BLT1, BLT2 (Leukotriene receptors) | Promote resolution of inflammation during the resolution phase, facilitating tissue repair. |
| Endocannabinoids (eCBs) | FAAH (Fatty Acid Amide Hydrolase), MAGL (Monoacylglycerol lipase) | CB1, CB2 (Cannabinoid receptors) | Modulate inflammation response and immune cell activity, exerting anti-inflammatory and neuroprotective effects. |
| Lysophospholipids/Sphingolipids (LPLs/SPs) | PLA2 (Phospholipase A2) | S1P1, S1P2, S1P3 (Sphingosine-1-phosphate receptors) | Exacerbate the inflammatory characteristics of glial cells and promote sustained inflammation. |